| Dr Jonathan Galaz Welden, MD | |
|
7373 Perkins Rd, Baton Rouge, LA 70808-4326 | |
| (225) 769-4044 | |
| Not Available |
| Full Name | Dr Jonathan Galaz Welden |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 18 Years |
| Location | 7373 Perkins Rd, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194935635 | NPI | - | NPPES |
| 206366 | Other | LA | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 206366 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baton Rouge Clinic, A Medical Corporation | 1254317001 | 218 |
News Archive
Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
People who perceive more discrimination in daily life have higher rates of sleep problems, based on both subjective and objective measures, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
According to a new study pregnant mothers with gestational diabetes are more likely to have kids with attention deficit hyperactivity disorder. Additionally if they have a poorer socioeconomic status, the child is 14 times more likely to be diagnosed with the behavioral disorder, researchers at Queens College and Mount Sinai School of Medicine found.
› Verified 4 days ago
| Entity Name | Baton Rouge Clinic, A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871546911 PECOS PAC ID: 1254317001 Enrollment ID: O20040624000911 |
News Archive
Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
People who perceive more discrimination in daily life have higher rates of sleep problems, based on both subjective and objective measures, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
According to a new study pregnant mothers with gestational diabetes are more likely to have kids with attention deficit hyperactivity disorder. Additionally if they have a poorer socioeconomic status, the child is 14 times more likely to be diagnosed with the behavioral disorder, researchers at Queens College and Mount Sinai School of Medicine found.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Galaz Welden, MD 7373 Perkins Rd, Baton Rouge, LA 70808-4326 Ph: (225) 769-4044 | Dr Jonathan Galaz Welden, MD 7373 Perkins Rd, Baton Rouge, LA 70808-4326 Ph: (225) 769-4044 |
News Archive
Fuisz Pharma today announced the development of a novel anti-abuse system intended for use with abuse prone drugs. This system seeks to address the misuse of addictive drugs with a particular emphasis on opiates and is applicable to all dosage forms.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.
People who perceive more discrimination in daily life have higher rates of sleep problems, based on both subjective and objective measures, reports a study in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society. The journal is published by Wolters Kluwer.
According to a new study pregnant mothers with gestational diabetes are more likely to have kids with attention deficit hyperactivity disorder. Additionally if they have a poorer socioeconomic status, the child is 14 times more likely to be diagnosed with the behavioral disorder, researchers at Queens College and Mount Sinai School of Medicine found.
› Verified 4 days ago
Dr. Jennifer L Rippon, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd Ste 409, Baton Rouge, LA 70808 Phone: 225-765-5864 Fax: 225-765-2013 | |
Gregory Fusilier, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 9103 Jefferson Hwy, Baton Rouge, LA 70809 Phone: 225-927-1190 Fax: 225-927-0988 | |
Dr. Yolanda Maria O'rourke, Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 7968 Essen Park, Baton Rouge, LA 70809 Phone: 225-761-6700 Fax: 225-761-6760 | |
Patricia D. Whatley, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Attn: Dee / Administration, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Frederick Cerise, Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3810 W Lakeshore Dr, Baton Rouge, LA 70808 Phone: 225-578-8886 | |
Dr. Jon Richard Jackson, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-4050 Fax: 225-765-4046 | |
Richard Frank Burroughs, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Earl K. Long Hospital, Lsu Unit, 5825 Airline Highway, Baton Rouge, LA 70805 Phone: 225-358-3938 |